First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study

NCT00537901 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Colonic Neoplasms
Rectal Neoplasms

Interventions

RADIATION: First-Line Bevacizumab and Chemotherapy
DRUG: Bevacizumab

Sponsor

King Faisal Specialist Hospital & Research Center